| |
|
October 25, 2007 -
The official launch of the Cardiospec in the Arabian Gulf Region
On October 25th and following the holy month of Ramadan, Medispec will hold the official launch of the Cardiospec in the Arabian Gulf Region.
During this event we will be presenting the most current clinical information regarding NI-CATh as well the most current treatments with Cardiospec.
The event will be held at the Novotel in the World Trade Center
in Dubai, UAE starting at 10:00 and ending at 14:00.
November 8, 2007 -
The official launch of the Cardiospec in Latin America
The Cardiospec Symposium - Medispec's first launching event of the cardiovascular system, in Latin America
will be held in November 8th in
Bogota,
Colombia
. The evnet will include an overview of the system, technical and clinical aspects, including hands-on training, presentations and an open discussion.
February 1, 2007 -
Announcing new Radialwave Deep Massage Therapy From Medispec
For the fast treatment of orthopedic pain in muscles, joints and tendons
Germantown, MD, February 1, 2007: Medispec LTD announces the launch of the Radialspec, a highly effective physical therapy device in relieving pain. Proven to be effective in treating muscle aches, lower back pain and tendonosis of the shoulder, biceps and Achilles heel, the Radialspec is based on applying pressure to trigger points in muscle, tendon and joint tissue in order to relieve acute pain and dysfunction in the body. Radial wave therapy can be used as a replacement for deep massage, laser, ultrasound and heat therapy devices in that it only requires an unprecedented five minutes of treatment time.
Radialspec Class I device is listed with the FDA and comes in a compact carrying case for easy transport. It's ergonomic design enables the user intuitive use of the applicator and control panel. With its excellent efficacy and short treatment time, the Radialspec is envisioned for use by Physical Therapy Centers and Sports Medicine Clinics around the world.
|
April
1, 2005 -
U.S. Food and Drug Administration Approves the Medispec
Orthospec ESWT Device
Germantown, MD, April 1, 2005: Medispec, Ltd. today
announced the FDA approval of its Orthospec Extracorporeal
Shock Wave Therapy System.. The Medispec Orthospec uses
Electrohydraulic spark gap technology to treat chronic
heel pain caused by proximal plantar fasciitis.
“The FDA approval of the Orthospec ESWT System
is yet another stride Medispec has taken in the effort
to make the most efficient and minimally-invasive medical
treatments available to patients everywhere,”
said Anil Dhingra, Vice President and COO of Medispec,
Ltd.
The Orthospec (ESWT) is a non-invasive therapy for the
treatment of heel pain. It employs shockwave technology
similar to that used in urological lithotripsy devices
to break kidney stones. Extracorporeal shock wave therapy
can be used to treat patients who have suffered from
chronic heel pain for at least six months and who have
been unresponsive to conservative treatments.
The Orthospec has been proven to be safe and effective
with its high-energy source and the largest (patented)
therapy zone in the industry. Additionally, there is
no anesthesia or imaging required during patient treatment.
Patients will benefit from the shorter recovery time,
compared to other treatments or surgical methods.
“This ESWT system offers the perfect combination
of clinical performance and flexibility. It was advantageous
for us to participate in the Orthospec clinical investigation.
The patients of my podiatric practice showed great improvement
in heel pain after being treated with this device,”
said Dr. Amir Assili of Gaithersburg, MD.
With more than 1000 installations worldwide, MEDISPEC’s
products are sold to governments, universities, and
private medical institutions in over 80 markets across
five continents. A global network of distributors enables
the worldwide availability of MEDISPEC products –
together with a complete customer support policy as
well as timely and responsive service.
|
